BAX and cholangiocarcinoma: On the other hand, increased ROS inhibits the pro-oncogenic effect of STAT3, which leads to a decrease in Bcl-2 and Bcl-cl levels and an increase in Bax expression, ultimately causing apoptosis in CCA.